Bioanalytical Systems to Release Second Quarter Fiscal 2017 Results on Monday, May 15, 2017
May 10 2017 - 1:00PM
Business Wire
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the
“Company”) today announced today that it will report financial
results for the second quarter and six months ended March 31, 2017,
prior to the market opening on Monday, May 15, 2017.
If there are any questions after the press release is issued,
please direct your comments to the investor relations contact noted
in this release.
About Bioanalytical Systems, Inc.
BASi is a pharmaceutical development company providing contract
research services and monitoring instruments to the world's leading
drug development companies and medical research organizations. The
company focuses on developing innovative services and products that
increase efficiency and reduce the cost of taking a new drug to
market. Visit www.BASinc.com for more about BASi.
This release may contain forward-looking statements that are
subject to risks and uncertainties including, but not limited to,
risks and uncertainties related to changes in the market and demand
for our products and services, the development, marketing and sales
of products and services, changes in technology, industry standards
and regulatory standards, and various market and operating risks
detailed in the company's filings with the Securities and Exchange
Commission.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170510006072/en/
Bioanalytical Systems, Inc.Jill C. Blumhoff, 765-497-8381Chief
Financial Officerjblumhoff@BASinc.com
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Apr 2023 to Apr 2024